Pharma
Pharma webinars, advisory boards and HCP education
$36B
47%
80%+
From conversation to decision
Turn the session into information your team can use
Every advisory board, HCP meeting and education session can become structured, reviewable information. Adelo brings together the recording, discussion, questions, participant response and session activity, so your team can search what happened, understand what needs attention and report on the programme with the original context in place.
AI can help identify potential off-label discussion, adverse-event mentions and custom compliance signals for authorised review, while keeping each item connected to the relevant speaker, moment and session.
$36B
Lost annually to underperforming drug launches.
Compliance
A slide deck can be approved. A live answer cannot be scripted.
Medicines promotion, off-label discussion and safety reporting can move beyond the approved deck the moment a question is asked. Adelo captures consent before entry, helps teams moderate Q&A and chat as they happen, and keeps a clear record of the session for authorised review.
Intelligence
See what your audience needed to hear
Questions, objections and points of confusion become searchable programme intelligence. Your team can see what needs clarifying, following up or addressing in the next session, while staying connected to the original speaker, question and discussion.
Content
One session. More useful channels.
Where rights, review and approval allow, a session can become clips, summaries and a searchable library for your wider HCP activity. Keep the source, context and review status connected before content reaches its next audience.
BUILT FOR PHARMA TEAMS
One platform for the teams around the programme
Adelo supports the people involved in planning, running, reviewing and learning from pharma webinars, advisory boards and education programmes.
Medical Affairs
Run advisory boards and KOL engagement with consent, moderated participation and a clear session record.
Medical Education
Deliver HCP education through professional video experiences, with audience participation and session activity connected to the programme.
Pharmacovigilance & Drug Safety
Surface potential safety signals for authorised review, connected to the moment and session in which they appeared.
Compliance & Legal
Keep consent, moderation and relevant session activity connected to the original conversation, rather than rebuilding the record afterwards.
Patient Engagement
Run patient programmes with consent, accessibility and appropriate routes for questions and participation.
Market Access
Turn payer-board discussion, objections and evidence requirements into searchable information your market-access team can review and use.
Commercial & Brand Teams
Keep approved messaging, resources and controlled Q&A connected to HCP education and launch activity.
Digital & Omnichannel Teams
Turn reviewed sessions into approved clips, summaries and searchable video resources for wider HCP engagement.
Procurement
Evaluate one connected platform for webinars, meetings, 1-to-1 and async sessions across your wider programme.
Questions
Before you run your next pharma programme
Does Adelo make our webinar compliant?
No. Adelo supports a more controlled and reviewable process by connecting consent, participation, moderation, potential compliance signals and session activity to the original conversation. Your medical, legal, regulatory and compliance teams remain responsible for review and approval.
Can Adelo detect an adverse event automatically?
Adelo’s AI can help identify a potential adverse-event mention and surface it for authorised human review. It does not determine whether an event is reportable.
Can Adelo identify potential off-label discussion?
Adelo’s AI can help flag potential off-label discussion and connect it to the relevant speaker, timestamp and session for authorised review.
Does moderated Q&A change our regulatory exposure?
Moderated Q&A gives your team a clearer, connected record of what was asked, what was shared and what was reviewed. It supports the process, rather than removing regulatory exposure.
Can we reuse an advisory board discussion as content?
Only where rights, review and approval allow. Adelo helps keep the source and review context connected, so your team can make that decision with the relevant information in place.
How is this different from a standard webinar platform?
A general platform hosts the session. Adelo is a professional video platform for health that also helps teams capture consent, manage participation, surface potential compliance or safety signals for review, understand the discussion and keep approved content connected to the original session.
Can Adelo fit into the systems we already use?
Adelo is designed to support the workflow your team already uses for programme delivery, review, reporting and follow-up.
How does Adelo support omnichannel content?
Where reviewed and approved, a session can become clips, summaries and a searchable video library for wider HCP activity. The original session, source material and review context remain available to your team.
Can we run a pharma programme live, async or both?
Yes. Run webinars, meetings and 1-to-1 sessions live, use an async window for longer participation, or combine both approaches within the same programme.
If an agency runs our programme in Adelo, who owns the data?
Your organisation retains the programme data. An agency can run the programme on your behalf while the session record, recordings and insight remain connected to your organisation.
See how Adelo fits your next pharma programme
Book a demo and see how Adelo applies to your next pharma webinar, advisory board, HCP education or KOL engagement programme.
From £299 a month. Quick to set up. No long contracts.
